RRAGD and hepatocellular carcinoma: As a target gene of miR-144-3p, RRAGD was over-expressed in HCC and participating in the HCC process by activating the mTOR signaling pathway which suggests LncRNA TUG1 and RRAGD expression should be considered as an undesired feature of HCC and other tumors.